Marico's Q1 FY26 results resurface: revenue rose 23% as India business accelerated; profit up 8%

Resurfacing an early-August announcement, Marico reported Q1 FY26 consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2% and international revenue increased 12.9%. The company also lifted its stake in Plix maker Satiya Nutraceuticals to 60% on a fully diluted basis.

— FiledSun, 13 Sept, 2026, 13:04 IST·First seen Sun, 13 Sept, 2026, 13:04 IST·Source Financial Express (via Wayback)

What happened

Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by a 27.2% rise in India revenue. The FMCG company also raised its stake in Plix

Key facts

  • Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
  • Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
  • Total income: Rs 3,315 crore
  • Other income: Rs 56 crore
  • Total expenses: Rs 2,659 crore versus Rs 2,075 crore
  • India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
  • International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
  • India segment PBT: Rs 469 crore
  • International segment profit: Rs 213 crore
  • Marico increased Plix maker Satiya Nutraceuticals stake to 60% on a fully diluted basis

Why this matters

Increasing ownership in Plix maker Satiya Nutraceuticals to 60% deepens Marico’s exposure to the fast-growing health and wellness nutrition segment.

What to watch

  • Sequential gross-margin movement and management commentary on copra, edible oil, packaging and advertising costs.
  • India volume growth versus price-led growth, especially in rural channels and core coconut-oil categories.
  • Saffola Foods, premium personal care and Plix growth rates, distribution expansion and profitability contribution.
  • International constant-currency growth, Bangladesh/Vietnam/MENA demand trends and foreign-exchange impact.
  • Any revision to full-year revenue-growth, operating-margin or EBITDA-margin guidance.
  • Take calibrated price increases or reduce promotional intensity in commodity-exposed brands to protect margins.
  • Increase distribution, digital marketing and innovation investment behind Parachute, Saffola and value-added personal-care offerings while India demand is strong.
  • Integrate Plix more deeply into Marico's distribution, procurement and e-commerce ecosystem to scale the health-and-wellness platform.
  • Use the stronger India business to fund selective international expansion, while managing currency and local-demand risk market by market.